Keighron, Jacqueline D.
Bonaventura, Jordi https://orcid.org/0000-0002-4745-0151
Li, Yang
Yang, Jae-Won https://orcid.org/0000-0001-8928-0130
DeMarco, Emily M.
Hersey, Melinda
Cao, Jianjing
Sandtner, Walter
Michaelides, Michael https://orcid.org/0000-0003-0398-4917
Sitte, Harald H. https://orcid.org/0000-0002-1339-7444
Newman, Amy Hauck https://orcid.org/0000-0002-4812-9474
Tanda, Gianluigi https://orcid.org/0000-0001-9526-9878
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (Z1A DA000611, Z1A 0000069, Z1A 000389)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Austrian Science Fund (P35589)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 18 April 2023
Revised: 17 May 2023
Accepted: 26 May 2023
First Online: 13 June 2023
Competing interests
: MM has received research funding from AstraZeneca, Redpin Therapeutics, and Attune Neurosciences. All the other authors report that they have no competing interests.